Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Nio

Showing results (111-120 of 155) with videos related to

Pageof 16
Sort By:
Biochemical and Biophysical Research Communications|April 26, 1995
Characterization of glucocorticoid response element of rat angiotensin II type 1A receptor geneS Murasawa, H Matsubara, M Kanasaki, et al.
The British Journal of Surgery|April 1, 1992
Metabolic bone disease following gastrectomy: assessment by dual energy X-ray absorptiometryK Inoue, K Shiomi, S Higashide, et al.
ISRN Radiology|June 27, 2014
An adrenal incidentaloma: how often is it detected and what are the consequences?E M Minnaar, K E Human, D Henneman, et al.
Internal Medicine (Tokyo, Japan)|September 1, 1995
Non-insulin-dependent diabetes mellitus complicated with idiopathic hypoparathyroidismH Itoh, Y Matsuda, M Nishiyama, et al.
Journal of Endourology|August 20, 2011
Computed tomography-urography for upper urinary tract imaging: is it required for all patients who present with hematuria?Evelyne C C Cauberg, C Y Nio, Jean M C H de la Rosette, et al.
Nihon Gan Chiryo Gakkai Shi|May 20, 1990
[A double blind study to evaluate the optimal dose and its frequency for oral administration of OK-432 (picibanil) by immunological parameters (the 2nd report)]T Shiraishi, Y Nio, S Imai, et al.
Journal of Surgical Oncology|May 1, 1993
Inhibitory effects of a cholecystokinin antagonist, loxiglumide (CR-1505), on the growth of freshly separated and xenografted human pancreatic cancerH Morimoto, Y Nio, M Tsubono, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1991
In vivo effects of human recombinant tumor necrosis factor alone and in combination with other biological response modifiers on human digestive organ cancer xenografts transplanted in nude miceY Nio, T Shiraishi, M Tsubono, et al.
Nihon Gan Chiryo Gakkai Shi|April 20, 1990
[A double blind study of the evaluation of the optimal dose and its frequency in oral administration of OK-432 (Picibanil) by immunological parameters (the 1st report)]T Shiraishi, Y Nio, S Imai, et al.
Anticancer Research|July 1, 1992
Antitumor activity of 5'-deoxy-5-fluorouridine in human digestive organ cancer xenografts and pyrimidine nucleoside phosphorylase activity in normal and neoplastic tissues from human digestive organsY Nio, H Kimura, M Tsubono, et al.
Pageof 16

Showing results (111-120 of 155) with videos related to

Sort By:
Pageof 16
Biochemical and Biophysical Research Communications|April 26, 1995
Characterization of glucocorticoid response element of rat angiotensin II type 1A receptor geneS Murasawa, H Matsubara, M Kanasaki, et al.
The British Journal of Surgery|April 1, 1992
Metabolic bone disease following gastrectomy: assessment by dual energy X-ray absorptiometryK Inoue, K Shiomi, S Higashide, et al.
ISRN Radiology|June 27, 2014
An adrenal incidentaloma: how often is it detected and what are the consequences?E M Minnaar, K E Human, D Henneman, et al.
Internal Medicine (Tokyo, Japan)|September 1, 1995
Non-insulin-dependent diabetes mellitus complicated with idiopathic hypoparathyroidismH Itoh, Y Matsuda, M Nishiyama, et al.
Journal of Endourology|August 20, 2011
Computed tomography-urography for upper urinary tract imaging: is it required for all patients who present with hematuria?Evelyne C C Cauberg, C Y Nio, Jean M C H de la Rosette, et al.
Nihon Gan Chiryo Gakkai Shi|May 20, 1990
[A double blind study to evaluate the optimal dose and its frequency for oral administration of OK-432 (picibanil) by immunological parameters (the 2nd report)]T Shiraishi, Y Nio, S Imai, et al.
Journal of Surgical Oncology|May 1, 1993
Inhibitory effects of a cholecystokinin antagonist, loxiglumide (CR-1505), on the growth of freshly separated and xenografted human pancreatic cancerH Morimoto, Y Nio, M Tsubono, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1991
In vivo effects of human recombinant tumor necrosis factor alone and in combination with other biological response modifiers on human digestive organ cancer xenografts transplanted in nude miceY Nio, T Shiraishi, M Tsubono, et al.
Nihon Gan Chiryo Gakkai Shi|April 20, 1990
[A double blind study of the evaluation of the optimal dose and its frequency in oral administration of OK-432 (Picibanil) by immunological parameters (the 1st report)]T Shiraishi, Y Nio, S Imai, et al.
Anticancer Research|July 1, 1992
Antitumor activity of 5'-deoxy-5-fluorouridine in human digestive organ cancer xenografts and pyrimidine nucleoside phosphorylase activity in normal and neoplastic tissues from human digestive organsY Nio, H Kimura, M Tsubono, et al.
Pageof 16